Effect of losartan on insulin plasma concentrations and LPL activity in adipose tissue of hypertensive rats

Hormone and Metabolic Research

Volumn 35, Issue 3, 2003, Pages 164-168

  Saranteas, T ^a   Lolis, E ^b   Mourouzis, C ^a   Potamianou, A ^a   Tesseromatis, C ^a   Varonos, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Insulin; Lipoprotein Lipase Activity; Losartan; Rats

Indexed keywords

ANGIOTENSIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN LIPASE; LOSARTAN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADRENAL GLAND; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; INSULIN BLOOD LEVEL; INSULIN RELEASE; KIDNEY ARTERY STENOSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; TREATMENT OUTCOME; UPREGULATION;

ADIPOSE TISSUE; ADRENAL GLANDS; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; CONSTRICTION; HYPERTENSION, RENOVASCULAR; INSULIN; LIPOPROTEIN LIPASE; LOSARTAN; MALE; ORGAN SIZE; RATS; RATS, WISTAR; RENAL ARTERY;

ANIMALIA;

EID: 0038292970     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39071     Document Type: Article

References (30)

1. Olivecrona T, Olivecrona G. Lipoprotein and hepatic lipase in lipoprotein metabolism. In: Betteridge DJ (ed). Lipoproteins in health and disease. London: Arnold, 1999: 225-239
2. Eckel RH. Lipoprotein lipase: A multifactional enzyme related to common metabolic disease. N Engl J Med 1989; 320: 1060-1068
3. Beisiegel U. New aspect on role of plasma lipase in lipoprotein catabolism and atherosclerosis. Atherosclerosis 1996; 124: 1-8
4. Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipoprotein lipase. J Clin Invext 1982; 69: 1119-1125
5. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Aterioscler Thromb 1991; 40: 214-216
6. Sechi L, Barttoli E. Molecular mechanisms of insulin resistance in arterial hypertension. Blood Pressure 1996; 5: 47-54
7. 1 receptor gene expression by posttranscriptional mechanisms. Circulation 1998; 98: 2453-2460
8. Opie LH, Gersh BJ. Angiotensin converting enzyme inhibitors and aldosterone antagonism. In: Opie LH (ed). Drugs for the heart. Philadelphia: WB Saunders, 2001: 127-128
9. Luzio SD, Dunseath G, Owens DR. Acute effects of valsartan on insulin sensitivity in obese, non hypertensive subjects with and without type 2 diabetes. Horm Metab Res 2002; 34: 271-274
10. Igarashi M, Hirata A, Yamaguchi H, Tsuchida H, Ohnuma H, Tominaga M. Candesartan inhibits carotid intimal thickening and ameliorates insulin resistance in balloon-injured diabetic rats. Hypertension. 2001; 38: 1255-1259
11. Vallottori MB. The Renin-Angiotensin system. Trends Pharmacol Sci 1987; 8: 69-74
12. Kagiyama S, Varela A, Phillips I, Galli M. Antisense inhibition of brain Renin-Angiotensin System decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension 2001; 37: 371-375
13. Timmermans PBMWM, Wong PC, Chiu at, Herblin WF, Benefield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacological Reviews 1993; 45: 205-251
14. Leung PS, Chan WP, Wong TP, Sernia C. Expression and localization of the renin- angiotensin system in the rat pancreas. J Endocrinol 1999; 160: 13-19
15. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue renin-angiotensin system in human pancreas. J Endocrinol 1999; 161: 317-322
16. Kelly KL, Leychock SG. Prostaglandin synthesis and metabolism in isolated pancreatic islet of the rat. Prostaglandinds 1981; 21: 756-769
17. Carlsson PO. The Renin-Angiotensin System in the endocrine pancreas. JOP 2001; 2: 26-32
18. Iwase M, Sandier S, Carlsson PO, Hellerstrom C, Jansson L. The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production. Eur J Endocrinol 2001; 144: 169-178
19. Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effect on islet blood flow and insulin secretion in rats. Diabetologia 1998; 41: 127-133
20. Tsopanakis C, Tesseromatis C. Cold swimming stress. Effect on serum lipids, lipoproteins and LCAT activity in male and female rats. Pharmacol Bioch Behav 1991; 38: 813-816
21. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 1992; 13: 329-380
22. Matsubara H. Pathophysiological role ofangiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998; 83: 1182-1191
23. Moan A, Ivar K, Eide IK, Kjeldsen SE. Metabolic and adrenergic characteristics of young men with insulin resistance. Blood Press Suppl 1996; 1: 30-37
24. Deshaies Y, Geloen A, Paulin A, Marette A, Bucowiecki LJ. Tissue-specific alterations in lipoprotein lipase activity in the rat after chronic infusion of isoproterenol. Horm Metab Res 1993; 25: 13-16
25. Sacks FM, Dzau VJ. Adrenergic effect on plasma lipoprotein metabolism. Speculation on mechanism of action. Am J Med 1986; Suppl. 2A: 71-81
26. Ahima RS, Filer JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332
27. Engeli S, Negrel R, Sharma M. Physiology and pathophysiology of the adipose tissue Renin-Angiotensin system. Hypertension 2000; 35: 1270-1277
28. Wong PC, Chiu AT, Duncia JV. Angiotensin II receptor antagonists and receptor subtypes. Trends Endocrinol Metab 1992; 3: 211-217
29. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metabol Rev 1994; 10: 407-416
30. Allen TJ, Cao ZM, Youssef S, Hulthen UL, Cooper ME. Role of local and systemic angiotensin II and bradykinin in experimental diabetic nephropathy-functional and structural studies. Diabetes 1997; 46: 1612-1618